DeepMed Research

Seoul St. Mary's Hospital

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Subsidiary

Employees: -

Market Cap: -

Website

Clinical Trials

Evaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft Recipients

Phase 4

Conditions: Kidney; Complications, Allograft

Interventions: Drug: Everolimus
Drug: Tacrolimus
Drug: Mycophenolic acid

First Posted Date: 2014-01-15

Last Posted Date: 2014-09-25

Lead Sponsor: Seoul St. Mary's Hospital

Target Recruit Count: 234

Registration Number: NCT02036554

Locations: 🇰🇷
division of nephrology;Seoul St Mary's Hospital, Seoul, Korea, Republic of

Patterns of ABL Mutation in Asian With Imatinib Resistant Chronic Myeloid Leukemia and Ph Positive Acute Lymphocytc Leuekmia Patients (AMICA)

Conditions: Chronic Myeloid Leukemia or Ph Positive ALL

First Posted Date: 2014-01-13

Last Posted Date: 2014-01-13

Lead Sponsor: Seoul St. Mary's Hospital

Target Recruit Count: 125

Registration Number: NCT02034656

Locations: 🇰🇷
Seoul St. Mary's Hospital, Seoul, Korea, Republic of

Effects of Drainage in Laparoscopic Cholecystectomy

Not Applicable

Completed

Conditions: Acute Cholecystitis
Empyema of Gallbladder
Abscess of Gallbladder

Interventions: Procedure: Laparoscopic cholecystectomy with drain insertion

First Posted Date: 2014-01-06

Last Posted Date: 2014-12-03

Lead Sponsor: Seoul St. Mary's Hospital

Target Recruit Count: 198

Registration Number: NCT02027402

Locations: 🇰🇷
Department of HBP Surgery, Seoul St. Mary's hospital, Seoul, Seocho-gu, Banopo-dong, Korea, Republic of

Comparison of the Efficacy and Safety of Closone and Clopidogrel With Aspirin

Phase 4

Completed

Conditions: Coronary Artery Disease

Interventions: Drug: Closone
Drug: Plavix with Astrix

First Posted Date: 2013-01-09

Last Posted Date: 2015-03-03

Lead Sponsor: Seoul St. Mary's Hospital

Target Recruit Count: 91

Registration Number: NCT01763749

Locations: 🇰🇷
Cardiovascular Center and Cardiology Division, Seoul St. Mary's Hospital, Seoul, Seochogu, Korea, Republic of

The Efficacy and Safety Study of ALbumin Therapy in Acute Ischemic Stroke

Phase 2

Terminated

Conditions: Cerebral Infarction

Interventions: Drug: 0.9 % Normal Saline
Biological: Human Serum Albumin 20

First Posted Date: 2012-09-13

Last Posted Date: 2013-12-02

Lead Sponsor: Seoul St. Mary's Hospital

Target Recruit Count: 2

Registration Number: NCT01684462

Locations: 🇰🇷
Ewha Womans University Mokdong Hospital, Mok-dong, Seoul, Korea, Republic of
🇰🇷
St. Vincent's hospital, Suwon, Gyeonggido, Korea, Republic of
🇰🇷
Seoul St. Mary's Hospital, Seocho-Gu, Seoul, Korea, Republic of

and more 1 locations

5 Day Versus 7 Day Azacitidine in Lower Risk Myelodysplastic Syndrome

Phase 2

Conditions: Myelodysplastic Syndrome

Interventions: Drug: Azacitidine

First Posted Date: 2012-07-30

Last Posted Date: 2015-11-20

Lead Sponsor: Seoul St. Mary's Hospital

Target Recruit Count: 92

Registration Number: NCT01652781

Locations: 🇰🇷
Seoul St. Mary's Hospital, Seoul, Korea, Republic of
🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of

Study to Evaluate Safety and Immunologic Biomarker of Rapamune in Patients With Stable Renal Transplant Recipient

Not Applicable

Conditions: Acute Rejection of Renal Transplant

First Posted Date: 2012-05-07

Last Posted Date: 2012-06-25

Lead Sponsor: Seoul St. Mary's Hospital

Target Recruit Count: 50

Registration Number: NCT01592253

Discontinuation Study of Imatinib in Adult CP CML Patients Who Have a Complete Molecular Response to Imatinib

Not Applicable

Conditions: Chronic Myeloid Leukemia
Imatinib
Complete Molecular Response

Interventions: Behavioral: Imatinib treatment discontinuing

First Posted Date: 2012-03-28

Last Posted Date: 2014-01-13

Lead Sponsor: Seoul St. Mary's Hospital

Target Recruit Count: 50

Registration Number: NCT01564836

Locations: 🇰🇷
Seoul St. Mary's Hospital, Seoul, Korea, Republic of

Safety and Efficacy Study of Ultrasonic Coagulation Device and Bipolar Energy Sealing System

Not Applicable

Conditions: Thyroid Cancer

Interventions: Device: Ultrasonic coagulation device (Harmonic ACE® scalpel)
Device: bipolar energy sealing system (LigaSure Precise)

First Posted Date: 2012-03-28

Last Posted Date: 2012-12-05

Lead Sponsor: Seoul St. Mary's Hospital

Target Recruit Count: 304

Registration Number: NCT01565486

Locations: 🇰🇷
Seoul St. Mary's Hospital, Seocho-gu, Seoul, Korea, Republic of

Prospective Investigation of Dynamics of ABL Mutations in Imatinib Failed CML Patients Treated With Nilotinib

Conditions: Chronic Myeloid Leukemia

Interventions: Drug: Nilotinib

First Posted Date: 2012-03-26

Last Posted Date: 2014-01-13

Lead Sponsor: Seoul St. Mary's Hospital

Target Recruit Count: 125

Registration Number: NCT01562847

Locations: 🇰🇷
Seoul St. Mary's Hospital, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy